Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Vaddi Krishna
CEO at Prelude Therapeutics. Filing since 20 Dec 2022.
CIK 0001824633
Company
Date
Role
Action
Shares
Amount
Of holding
PRLD
Prelude Therapeutics Inc
25 Mar 2025
CEO
Bought
675,000
$467.44K
51.0%
PRLD
Prelude Therapeutics Inc
21 Mar 2025
CEO
Bought
15,000
$10.96K
1.1%
PRLD
Prelude Therapeutics Inc
20 Mar 2025
CEO
Bought
5,416
$3.95K
0.4%
PRLD
Prelude Therapeutics Inc
17 Mar 2025
CEO
Bought
9,106
$6.83K
0.7%
PRLD
Prelude Therapeutics Inc
14 Mar 2025
CEO
Bought
29,999
$22.63K
2.4%
PRLD
Prelude Therapeutics Inc
13 Mar 2025
CEO
Bought
50,000
$35.82K
4.1%
PRLD
Prelude Therapeutics Inc
12 Mar 2025
CEO
Bought
47,500
$33.74K
4.1%
PRLD
Prelude Therapeutics Inc
31 Dec 2024
CEO
Bought
5,000
$6.04K
3.6%
PRLD
Prelude Therapeutics Inc
30 Dec 2024
CEO
Bought
10,000
$12.00K
7.8%
PRLD
Prelude Therapeutics Inc
19 Dec 2024
CEO
Bought
6,888
$6.12K
5.7%
PRLD
Prelude Therapeutics Inc
18 Dec 2024
CEO
Bought
100,000
$93.21K
9.4%
PRLD
Prelude Therapeutics Inc
25 May 2023
CEO
Bought
900
$4.78K
0.1%
PRLD
Prelude Therapeutics Inc
24 May 2023
CEO
Bought
1,000
$5.01K
0.1%
PRLD
Prelude Therapeutics Inc
23 May 2023
CEO
Bought
11,856
$66.75K
1.1%
PRLD
Prelude Therapeutics Inc
20 Dec 2022
CEO
Bought
19,188
$98.45K
18.9%
15 decisions on file.
